Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma

BACKGROUND: Distal cholangiocarcinoma (DCC) presents as one of the relatively rare malignant tumors in the digestive system and has a poor long-term prognosis. Curative resection is currently the most appropriate therapy for patients with DCC because of the lack of effective adjuvant therapies. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tao, Lyu, Shao-Cheng, Zhou, Lin, Wang, Jing, Li, Han, He, Qiang, Lang, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462080/
https://www.ncbi.nlm.nih.gov/pubmed/34621478
http://dx.doi.org/10.4240/wjgs.v13.i9.1025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462080/
https://www.ncbi.nlm.nih.gov/pubmed/34621478
http://dx.doi.org/10.4240/wjgs.v13.i9.1025

Ejemplares similares